Open AccessRetinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience
Author(s) -
Nishikant Damle,
Manish Patnecha,
Praveen Kumar,
Sagar Maharjan,
Chandrasekhar Bal
Publication year - 2011
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.103997
Subject(s) - medicine , thyroid cancer , retinoic acid , thyroglobulin , follicular phase , follicular thyroid cancer , radioiodine therapy , thyroid , gastroenterology , disease , endocrinology , papillary thyroid cancer , oncology , biochemistry , chemistry , gene
Dedifferentiation of thyroid follicular cells renders radioiodine therapy ineffective in patients of differentiated thyroid cancer (DTC). An alternative therapy to treat the disease or reinduce radioiodine uptake is necessary.